Yuji Eso

Percutaneous radiofrequency ablation therapy for hepatocellular carcinoma: a proposed new grading system for the ablative margin and prediction of local tumor progression and its validation

Hiroki Nishikawa, Tadashi Inuzuka, Haruhiko Takeda et al. · Journal of Gastroenterology · 2011 · 73 citations

Medicine, Oncology, Surgery +16

Laparoscopic liver resection versus percutaneous radiofrequency ablation for small hepatocellular carcinoma

Satoshi Ogiso, Satoru Seo, Yuji Eso et al. · HPB · 2020 · 67 citations

Medicine, Oncology, Surgery +14

Proliferating EpCAM-Positive Ductal Cells in the Inflamed Liver Give Rise to Hepatocellular Carcinoma

Tomonori Matsumoto, Atsushi Takai, Yuji Eso et al. · Cancer Research · 2017 · 63 citations

Medicine, Cell Biology, Oncology +17

Pretreatment Neutrophil-to-Lymphocyte Ratio as a Predictive Marker of Response to Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma

Yuji Eso, Haruhiko Takeda, Kojiro Taura et al. · Current Oncology · 2021 · 61 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis C virus infection receiving interferon therapy: a single center study

Yukio Osaki, Yoshihide Ueda, Hiroyuki Marusawa et al. · Journal of Gastroenterology · 2011 · 51 citations

Medicine, Infectious Diseases, Oncology +14